Cannabis Bioscience International Holdings, Inc. (CBIH) Gross Margin (2022 - 2026)

Cannabis Bioscience International Holdings has disclosed Gross Margin across 5 years of filings, most recently posting 72.82% for Q1 2026.

• In Q1 2026, Gross Margin rose 10273.0% year-over-year to 72.82%; the TTM figure through Feb 2026 stood at 78.78% (down 801.0% YoY), while the FY2025 annual figure was 86.76%, up 509.0% from the prior year.
• Gross Margin came in at 72.82% for Q1 2026 at Cannabis Bioscience International Holdings, down from 80.29% in the prior quarter.
• In the past five years, Gross Margin ranged from a high of 95.33% in Q3 2024 to a low of 29.9% in Q1 2025.
• Average Gross Margin over 5 years is 70.71%, with a median of 78.31% recorded in 2023.
• Year-over-year, Gross Margin tumbled 9747 bps in 2025 and soared 10273 bps in 2026.
• Over 5 years, Gross Margin stood at 91.41% in 2022, then decreased by 17 bps to 76.33% in 2023, then advanced by 17 bps to 89.49% in 2024, then retreated by 10 bps to 80.29% in 2025, then retreated by 9 bps to 72.82% in 2026.
• Per Business Quant data, the three most recent Gross Margin figures were 72.82% in Q1 2026, 80.29% in Q4 2025, and 66.35% in Q3 2025.